Tag: biomedical
-
Patent Set for Long-Term Drug Capsules
Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities.
-
Companies Partner on High-Resolution 3-D Tissue Printer
Two developers of tissue engineering technologies are building a three-dimensional bioprinter that produces high resolution, finely structured human tissue, including tiny blood vessels.
-
RNA Biotech Raises $604M in IPO
Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million.
-
Post-Surgical Opioid Prescriptions Safely Cut
A cancer center reduced its opioid pain prescriptions for surgery for a year, without patients reporting more pain, complications, or requests for more pills.
-
Report – 289 Cell and Gene Therapies in Development
A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration.
-
Self-Powered Sun Exposure Chip, App Developed
A tiny wireless sensor chip measuring exposure to ultraviolet or UV rays from the sun, developed by a university lab, is now offered by a cosmetics company with an accompanying smartphone app.
-
Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study
A collaboration of Mount Sinai medical center, drug maker Sanofi, and data science company Sema4 aims to track people with asthma for 5 years to help develop personalized treatments for the disease.
-
Immune Cell Chips to Launch into Space for Microgravity Tests
Chip devices with human immune system and stem cells are among the cargo set for launch today to the International Space Station.
-
FDA Identifies Database to Evaluate Precision Diagnostics
The Food and Drug Administration identified a public database of genomics and diseases as a resource to assess new diagnostics tests using genetic data for precision medicine.
-
Trial Results Show Gene Transfers Reverse Sickle Cell Disease
Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year.